Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$34.5 - $42.19 $114,643 - $140,197
-3,323 Reduced 6.92%
44,693 $1.88 Million
Q1 2023

May 15, 2023

BUY
$33.32 - $40.98 $602,492 - $741,000
18,082 Added 60.41%
48,016 $1.71 Million
Q4 2022

Feb 15, 2023

BUY
$25.32 - $51.45 $63,274 - $128,573
2,499 Added 9.11%
29,934 $1.1 Million
Q3 2022

Nov 16, 2022

BUY
$46.5 - $79.14 $173,073 - $294,559
3,722 Added 15.7%
27,435 $1.29 Million
Q2 2022

Aug 23, 2022

SELL
$63.06 - $84.75 $285,220 - $383,324
-4,523 Reduced 16.02%
23,713 $1.7 Million
Q2 2022

Aug 16, 2022

BUY
$63.06 - $84.75 $486,507 - $653,846
7,715 Added 37.6%
28,236 $2.02 Million
Q1 2022

May 16, 2022

BUY
$74.15 - $99.36 $857,767 - $1.15 Million
11,568 Added 129.21%
20,521 $1.66 Million
Q4 2021

Feb 14, 2022

BUY
$86.01 - $102.89 $162,472 - $194,359
1,889 Added 26.74%
8,953 $919,000
Q3 2021

Nov 16, 2021

BUY
$84.7 - $96.31 $45,822 - $52,103
541 Added 8.29%
7,064 $618,000
Q2 2021

Aug 16, 2021

SELL
$76.44 - $89.57 $200,043 - $234,404
-2,617 Reduced 28.63%
6,523 $584,000
Q1 2021

May 17, 2021

BUY
$67.36 - $80.76 $594,182 - $712,383
8,821 Added 2765.2%
9,140 $693,000
Q4 2020

Feb 16, 2021

BUY
$53.08 - $69.86 $1,592 - $2,095
30 Added 10.38%
319 $22,000
Q3 2020

Nov 17, 2020

BUY
$51.29 - $65.09 $6,154 - $7,810
120 Added 71.01%
289 $16,000
Q2 2020

Aug 14, 2020

BUY
$34.32 - $62.43 $5,800 - $10,550
169 New
169 $10,000
Q4 2019

Feb 14, 2020

SELL
$48.0 - $59.55 $8,112 - $10,063
-169 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$46.64 - $55.39 $4,664 - $5,539
-100 Reduced 37.17%
169 $9,000
Q1 2019

May 15, 2019

SELL
$36.91 - $55.7 $6,016 - $9,079
-163 Reduced 37.73%
269 $14,000
Q2 2018

Aug 13, 2018

BUY
$35.0 - $48.9 $15,120 - $21,124
432 New
432 $20,000

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.